Original Research
Published on 16 Aug 2024
The effectiveness of nirsevimab in reducing the burden of disease due to respiratory syncytial virus (RSV) infection over time in the Madrid region (Spain): a prospective population-based cohort study
in Infectious Diseases: Epidemiology and Prevention
- José Francisco Barbas Del Buey
- Jesús Íñigo Martínez
- María Ángeles Gutiérrez Rodríguez
- Marcos Alonso García
- Amaya Sánchez-Gómez
- María Dolores Lasheras Carbajo
- Susana Jiménez Bueno
- María Dolores Esteban Vasallo
- María Alejandra López Zambrano
- Cristina Calvo Rey
Frontiers in Public Health
doi 10.3389/fpubh.2024.1441786